ESTRO meets Asia 2024 - Abstract Book

S209

Interdisciplinary – Lower GI

ESTRO meets Asia 2024

Conclusion:

This prospective phase II trial for LARC patients showed a clinically relevant increase of 10% in pathological CR in patients treated with preoperative radiochemotherapy combined with locoregional HT compared with only radiochemotherapy, mostly with mild toxicities.

Keywords: Locally advanced rectal cancer, thermoradiation

374

Digital Poster

Quality of Life after Chemoradiation in Locally advanced Rectal cancer: A Systematic Review

Andree Kurniawan 1 , Angela Giselvania 2 , Findy Prasetyawati 3 , Felix Wijovi 4 , Chandra Sari 3 , Devi Astri Rivera Amelia 3 , Deden Djatnika 3 , Muhammad Arman Nasution 3 1 Internal Medicine, Faculty of Medicine, Pelita Harapan University, Tangerang, Indonesia. 2 Radiotherapy, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia. 3 Hematology and Medical Oncology, Internal Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia. 4 Medicine, Faculty of Medicine, Pelita Harapan University, Tangerang, Indonesia

Purpose/Objective:

Colorectal cancer is one of common cancer. Rectal cancers comprise a third of colorectal cases. Locally advanced rectal cancer is treated with three modalities therapy consisting of neoadjuvant chemoradiation, surgery, followed by adjuvant chemotherapy. The Quality of life (QoL) is central to treatment goals and there is limited data on quality of life (QoL) in locally advanced rectal cancer. This study aimed to evaluate the QoL of patients with locally advanced rectal cancer after chemoradiotherapy.

Material/Methods: